Core Insights - START has formed a strategic partnership with Trialing to enhance access to oncology clinical trials across Europe, aiming to improve physician awareness and streamline patient referrals [1][2][3] Group 1: Partnership Objectives - The collaboration will distribute curated information on active oncology clinical trials and provide real-time updates to medical oncologists, thereby expanding patient access to innovative cancer therapies [2][4] - The partnership is designed to reduce barriers in the referral process and increase physician engagement with START's clinical trial sites [3][5] Group 2: Technology and Innovation - Trialing utilizes innovative technology and structured clinical decision pathways to facilitate faster identification of appropriate studies for physicians, thereby reducing delays in trial participation [3][9] - The platform will provide dynamic study updates, ensuring that physicians have current information on eligibility criteria and enrollment status [5][9] Group 3: Organizational Background - START is recognized as the world's largest community-based network of clinical trial sites specializing in early-phase oncology trials, having conducted over 1,000 early-phase clinical trials [7] - Trialing is a physician-driven platform that connects oncologists, hospitals, patients, and pharmaceutical sponsors, focusing on improving access to clinical trials [9]